Medtronic's quarterly revenues fell about $80 million short of Wall Street's consensus expectation, which execs attributed to "transient" challenges, many of which they said were recognized too late in the quarter to correct. At $7.717 billion, year-over-year revenue growth was 2.3% as reported and 2.6% on an organic basis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,